Befunolol: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
m Protected "Befunolol": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))
 
Kiran Singh (talk | contribs)
No edit summary
 
Line 1: Line 1:
{{Drugbox
{{Drugbox
| IUPAC_name        = 1-[7-[2-hydroxy-3-(propan-2-ylamino)propoxy]-<br>1-benzofuran-2-yl]ethanone
| IUPAC_name        = 1-[7-[2-hydroxy-3-(propan-2-ylamino)propoxy]-<br>1-benzofuran-2-yl]ethanone
| image            = Befunolol.svg
| image            = Befunolol.png
| CAS_number        = 39552-01-7
| CAS_number        = 39552-01-7
| ATC_prefix        = S01
| ATC_prefix        = S01
Line 24: Line 24:
| routes_of_administration =  
| routes_of_administration =  
}}
}}
__Notoc__
{{SI}}
{{CMG}}
==Overview==
'''Befunolol''' ([[International Nonproprietary Name|INN]]) is a [[beta blocker]] with [[beta blocker#Intrinsic sympathomimetic activity|intrinsic sympathomimetic activity]] used in the management of [[glaucoma|open-angle glaucoma]].
'''Befunolol''' ([[International Nonproprietary Name|INN]]) is a [[beta blocker]] with [[beta blocker#Intrinsic sympathomimetic activity|intrinsic sympathomimetic activity]] used in the management of [[glaucoma|open-angle glaucoma]].


{{pharmacology-stub}}
 
{{Antiglaucoma preparations and miotics}}
{{Antiglaucoma preparations and miotics}}


[[Category:Beta blockers]]
[[Category:Beta blockers]]
[[Category:Drug]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 14:43, 13 April 2015

Befunolol
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H21NO4
Molar mass291.342 g/mol

WikiDoc Resources for Befunolol

Articles

Most recent articles on Befunolol

Most cited articles on Befunolol

Review articles on Befunolol

Articles on Befunolol in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Befunolol

Images of Befunolol

Photos of Befunolol

Podcasts & MP3s on Befunolol

Videos on Befunolol

Evidence Based Medicine

Cochrane Collaboration on Befunolol

Bandolier on Befunolol

TRIP on Befunolol

Clinical Trials

Ongoing Trials on Befunolol at Clinical Trials.gov

Trial results on Befunolol

Clinical Trials on Befunolol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Befunolol

NICE Guidance on Befunolol

NHS PRODIGY Guidance

FDA on Befunolol

CDC on Befunolol

Books

Books on Befunolol

News

Befunolol in the news

Be alerted to news on Befunolol

News trends on Befunolol

Commentary

Blogs on Befunolol

Definitions

Definitions of Befunolol

Patient Resources / Community

Patient resources on Befunolol

Discussion groups on Befunolol

Patient Handouts on Befunolol

Directions to Hospitals Treating Befunolol

Risk calculators and risk factors for Befunolol

Healthcare Provider Resources

Symptoms of Befunolol

Causes & Risk Factors for Befunolol

Diagnostic studies for Befunolol

Treatment of Befunolol

Continuing Medical Education (CME)

CME Programs on Befunolol

International

Befunolol en Espanol

Befunolol en Francais

Business

Befunolol in the Marketplace

Patents on Befunolol

Experimental / Informatics

List of terms related to Befunolol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Befunolol (INN) is a beta blocker with intrinsic sympathomimetic activity used in the management of open-angle glaucoma.


Template:Antiglaucoma preparations and miotics

Template:WikiDoc Sources